Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults

Contemporary Clinical Trials

Volumn 47, Issue , 2016, Pages 185-195

  Gold, Diane R ^a,b,c   Litonjua, Augusto A ^a,c   Carey, Vincent J ^a,c   Manson, JoAnn E ^a,b,c   Buring, Julie E ^a,b,c   Lee, I Min ^a,b,c   Gordon, David ^a   Walter, Joseph ^a   Friedenberg, Georgina ^a   Hankinson, John L ^d   Copeland, Trisha ^a   Luttmann Gibson, Heike ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Hankinson Consulting Inc   (United States)

Author keywords

COPD; Lung function; Omega 3 fatty acids; Randomized clinical trial; Respiratory symptoms; Vitamin D

Indexed keywords

COLECALCIFEROL; DOCOSAHEXAENOIC ACID; DRUG COMBINATION; ICOSAPENTAENOIC ACID; OMEGA 3 ACID ETHYL ESTER; VITAMIN;

ACUTE DISEASE; AGED; ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIETARY SUPPLEMENT; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; LUNG; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ASTHMA; CHOLECALCIFEROL; CLINICAL PROTOCOLS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESEARCH DESIGN; TREATMENT OUTCOME; VITAMINS;

EID: 84955439349     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2016.01.003     Document Type: Article

References (61)

1. Celli B.R., Barnes P.J. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007, 29(6):1224-1238.
2. Peto R., Speizer F.E., Cochrane A.L., Moore F., Fletcher C.M., Tinker C.M., Higgins I.T., Gray R.G., Richards S.M., Gilliland J., Norman-Smith B. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20years of prospective observation. Am. Rev. Respir. Dis. 1983, 128(3):491-500.
3. Zasloff M. Inducing endogenous antimicrobial peptides to battle infections. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(24):8913-8914.
4. Hiemstra P.S. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem. Soc. Trans. 2006, 34(Pt 2):276-278.
5. Wordley J., Walters S., Ayres J.G. Short term variations in hospital admissions and mortality and particulate air pollution. Occup. Environ. Med. 1997, 54(2):108-116.
6. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000, 117(2 Suppl.):1S-4S.
7. Mannino D.M., Homa D.M., Akinbami L.J., Moorman J.E., Gwynn C., Redd S.C. Surveillance for asthma-United States, 1980-1999. MMWR Surveill. Summ. 2002, 51(1):1-13.
8. Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H., Amann M., Anderson H.R., Andrews K.G., Aryee M., Atkinson C., Bacchus L.J., Bahalim A.N., Balakrishnan K., Balmes J., Barker-Collo S., Baxter A., Bell M.L., Blore J.D., Blyth F., Bonner C., Borges G., Bourne R., Boussinesq M., Brauer M., Brooks P., Bruce N.G., Brunekreef B., Bryan-Hancock C., Bucello C., Buchbinder R., Bull F., Burnett R.T., Byers T.E., Calabria B., Carapetis J., Carnahan E., Chafe Z., Charlson F., Chen H., Chen J.S., Cheng A.T., Child J.C., Cohen A., KE C., Cowie B.C., Darby S., Darling S., Davis A., Degenhardt L., Dentener F., Des Jarlais D.C., Devries K., Dherani M., Ding E.L., Dorsey E.R., Driscoll T., Edmond K., Ali S.E., Engell R.E., Erwin P.J., Fahimi S., Falder G., Farzadfar F., Ferrari A., Finucane M.M., Flaxman S., Fowkes F.G., Freedman G., Freeman M.K., Gakidou E., Ghosh S., Giovannucci E., Gmel G., Graham K., Grainger R., Grant B., Gunnell D., Gutierrez H.R., Hall W., Hoek H.W., Hogan A., Hosgood H.D., Hoy D., Hu H., Hubbell B.J., Hutchings S.J., Ibeanusi S.E., Jacklyn G.L., Jasrasaria R., Jonas J.B., Kan H., Kanis J.A., Kassebaum N., Kawakami N., Khang Y.H., Khatibzadeh S., Khoo J.P., Kok C., Laden F., Lalloo R., Lan Q., Lathlean T., Leasher J.L., Leigh J., Li Y., Lin J.K., Lipshultz S.E., London S., Lozano R., Lu Y., Mak J., Malekzadeh R., Mallinger L., Marcenes W., March L., Marks R., Martin R., McGale P., McGrath J., Mehta S., Mensah G.A., Merriman T.R., Micha R., Michaud C., Mishra V., Mohd Hanafiah K., Mokdad A.A., Morawska L., Mozaffarian D., Murphy T., Naghavi M., Neal B., Nelson P.K., Nolla J.M., Norman R., Olives C., Omer S.B., Orchard J., Osborne R., Ostro B., Page A., Pandey K.D., Parry C.D., Passmore E., Patra J., Pearce N., Pelizzari P.M., Petzold M., Phillips M.R., Pope D., Pope C.A., Powles J., Rao M., Razavi H., Rehfuess E.A., Rehm J.T., Ritz B., Rivara F.P., Roberts T., Robinson C., Rodriguez-Portales J.A., Romieu I., Room R., Rosenfeld L.C., Roy A., Rushton L., Salomon J.A., Sampson U., Sanchez-Riera L., Sanman E., Sapkota A., Seedat S., Shi P., Shield K., Shivakoti R., Singh G.M., Sleet D.A., Smith E., Smith K.R., Stapelberg N.J., Steenland K., Stockl H., Stovner L.J., Straif K., Straney L., Thurston G.D., Tran J.H., Van Dingenen R., van Donkelaar A., Veerman J.L., Vijayakumar L., Weintraub R., Weissman M.M., White R.A., Whiteford H., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams W., Wilson N., Woolf A.D., Yip P., Zielinski J.M., Lopez A.D., Murray C.J., Ezzati M., AlMazroa M.A., Memish Z.A. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2224-2260.
9. Institute of Medicine.Committee to Review Dietary Reference Intakes for Vitamin D, Calcium Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, Washington, DC.
10. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 2011, 96(1):53-58.
11. Kupferschmidt K. Uncertain verdict as vitamin D goes on trial. Science 2012, 337(6101):1476-1478.
12. LeBoff M.S., Yue A.Y., Copeland T., Cook N.R., Buring J.E., Manson J.E. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp. Clin. Trials 2015, 41:259-268.
13. Moreno-Macias H., Romieu I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J. Allergy Clin. Immunol. 2014, 133(5):1237-1244. (quiz 1245).
14. Koli K., Keski-Oja J. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000, 11(4):221-229.
15. Zasloff M. Fighting infections with vitamin D. Nat. Med. 2006, 12(4):388-390.
16. Zasloff M. Sunlight, vitamin D, and the innate immune defenses of the human skin. J. Investig. Dermatol. 2005, 125(5):xvi-xvii.
17. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773.
18. Moromizato T., Litonjua A.A., Braun A.B., Gibbons F.K., Giovannucci E., Christopher K.B. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit. Care Med. 2014, 42(1):97-107.
19. Quraishi S.A., Litonjua A.A., Moromizato T., Gibbons F.K., Camargo C.A., Giovannucci E., Christopher K.B. Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections. JPEN J. Parenter. Enteral Nutr. 2015, 39(1):47-55.
20. Quraishi S.A., Litonjua A.A., Moromizato T., Gibbons F.K., Camargo C.A., Giovannucci E., Christopher K.B. Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am. J. Clin. Nutr. 2013, 98(4):952-959.
21. Lange N.E., Sparrow D., Vokonas P., Litonjua A.A. Vitamin D deficiency, smoking, and lung function in the normative aging study. Am. J. Respir. Crit. Care Med. 2012, 186(7):616-621.
22. Confino-Cohen R., Brufman I., Goldberg A., Feldman B.S. Vitamin D, asthma prevalence and asthma exacerbations: a large adult population-based study. Allergy 2014.
23. Camargo C.A., Manson J.E. Vitamin D supplementation and risk of infectious disease: no easy answers. Am. J. Clin. Nutr. 2014, 99(1):3-4.
24. Gold D.R., Manson J.E. Severe vitamin D deficiency: a prerequisite for COPD responsiveness to vitamin D supplementation?. Ann. Intern. Med. 2012, 156(2):156-157.
25. Wendell S.G., Baffi C., Holguin F. Fatty acids, inflammation, and asthma. J. Allergy Clin. Immunol. 2014, 133(5):1255-1264.
26. Baraldi E., Carraro S., Alinovi R., Pesci A., Ghiro L., Bodini A., Piacentini G., Zacchello F., Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003, 58(6):505-509.
27. Manson J.E., Bassuk S.S., Lee I.M., Cook N.R., Albert M.A., Gordon D., Zaharris E., Macfadyen J.G., Danielson E., Lin J., Zhang S.M., Buring J.E. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 2012, 33(1):159-171.
28. Pradhan A.D., Manson J.E. Update on the vitamin D and OmegA-3 trial (VITAL). J. Steroid Biochem. Mol. Biol. 2015.
29. Regan E.A., Hokanson J.E., Murphy J.R., Make B., Lynch D.A., Beaty T.H., Curran-Everett D., Silverman E.K., Crapo J.D. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010, 7(1):32-43.
30. Bowler R.P., Kim V., Regan E., Williams A., Santorico S.A., Make B.J., Lynch D.A., Hokanson J.E., Washko G.R., Bercz P., Soler X., Marchetti N., Criner G.J., Ramsdell J., Han M.K., Demeo D., Anzueto A., Comellas A., Crapo J., Dransfield M., Wells J.M., Hersh C.P., MacIntyre N., Martinez F., Nath H., Niewoehner D., Sciurba F., Sharafkhaneh A., Silverman E.K., van Beek E.J., Wilson C., Wendt C., Wise R.A. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest 2014.
31. Toren K., Brisman J., Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993, 104(2):600-608.
32. Ferris B.G. Epidemiology Standardization Project (American Thoracic Society). Am. Rev. Respir. Dis. 1978, 118(6 Pt 2):1-120.
33. Wan E.S., Castaldi P.J., Cho M.H., Hokanson J.E., Regan E.A., Make B.J., Beaty T.H., Han M.K., Curtis J.L., Curran-Everett D., Lynch D.A., DeMeo D.L., Crapo J.D., Silverman E.K. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir. Res. 2014, 15:89.
34. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., Redd S.C. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill. Summ. 2002, 51(6):1-16.
35. Standardization of Spirometry 1994 Update. American Thoracic Society. Am. J. Respir. Crit. Care Med. 1995, 152(3):1107-1136.
36. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007, 356(8):775-789.
37. Juniper E.F., Bousquet J., Abetz L., Bateman E.D. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir. Med. 2006, 100(4):616-621.
38. Juniper E.F., Svensson K., Mork A.C., Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir. Med. 2005, 99(5):553-558.
39. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54(7):581-586.
40. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., RA M., Pinto Plata V., HJ C. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350(10):1005-1012.
41. Linehan K. Medicare advantage update: benefits, enrollment, and payments after the ACA. Issue Brief Natl. Health Policy Forum 2013, (850):1-12.
42. Zanobetti A., Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ. Health Perspect. 2005, 113(8):978-982.
43. Barnes P.J., Drazen J.M., Rennard S.I., Thomson N.C. Asthma and COPD: Basic Mechanisms and Clinical Management 2009, Academic Press, San Diego. second ed.
44. Hankinson J.L., Crapo R.O., Jensen R.L. Spirometric reference values for the 6-s FVC maneuver. Chest 2003, 124(5):1805-1811.
45. Cole T.J., Stanojevic S., Stocks J., Coates A.L., Hankinson J.L., Wade A.M. Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat. Med. 2009, 28(5):880-898.
46. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen OF, Pellegrino R., Viegi G., Wanger J. Standardisation of spirometry. Eur. Respir. J. 2005, 26(2):319-338.
47. Miller M.R., Crapo R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen OF, Pellegrino R., Viegi G., Wanger J. General considerations for lung function testing. Eur. Respir. J. 2005, 26(1):153-161.
48. Stanojevic S., Wade A., Stocks J., Hankinson J., Coates A.L., Pan H., Rosenthal M., Corey M., Lebecque P., Cole T.J. Reference ranges for spirometry across all ages: a new approach. Am. J. Respir. Crit. Care Med. 2008, 177(3):253-260.
49. Lee T.A., Weaver F.M., Weiss K.B. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J. Gen. Intern. Med. 2007, 22(1):62-67.
50. U.S.Department of Health and Human Services The health consequences of smoking: a report of the surgeon general 2004, Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
51. Fry A.M., Shay D.K., Holman R.C., Curns A.T., Anderson L.J. Trends in hospitalizations for pneumonia among persons aged 65years or older in the United States, 1988-2002. J. Am. Med. Assoc. 2005, 294(21):2712-2719.
52. Modern Applied Statistics with S 2002, Springer, New York. fourth ed. W.N. Venables, B.D. Ripley (Eds.).
53. Lehouck A., Mathieu C., Carremans C., Baeke F., Verhaegen J., Van Eldere J., Decallonne B., Bouillon R., Decramer M., Janssens W. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2012, 156(2):105-114.
54. Castro M., King T.S., Kunselman S.J., Cabana M.D., Denlinger L., Holguin F., Kazani S.D., Moore W.C., Moy J., Sorkness C.A., Avila P., Bacharier L.B., Bleecker E., Boushey H.A., Chmiel J., Fitzpatrick A.M., Gentile D., Hundal M., Israel E., Kraft M., Krishnan J.A., LaForce C., Lazarus S.C., Lemanske R., Lugogo N., Martin R.J., Mauger D.T., Naureckas E., Peters S.P., Phipatanakul W., Que L.G., Sheshadri A., Smith L., Solway J., Sullivan-Vedder L., Sumino K., Wechsler M.E., Wenzel S., White S.R., Sutherland E.R. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA 2014, 311(20):2083-2091.
55. Hollis B.W., Wagner C.L. Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 2013, 98(12):4619-4628.
56. Weiss S.T., Litonjua A.A. Vitamin D dosing for infectious and immune disorders. Thorax 2015, 70(10):919-920.
57. Murdoch D.R., Slow S., Chambers S.T., Jennings L.C., Stewart A.W., Priest P.C., Florkowski C.M., Livesey J.H., Camargo C.A., Scragg R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. J. Am. Med. Assoc. 2012, 308(13):1333-1339.
58. Martineau A.R., MacLaughlin B.D., Hooper R.L., Barnes N.C., Jolliffe D.A., Greiller C.L., Kilpin K., McLaughlin D., Fletcher G., Mein C.A., Hoti M., Walton R., Grigg J., Timms P.M., Rajakulasingam R.K., Bhowmik A., Rowe M., Venton T.R., Choudhury A.B., Simcock D.E., Sadique Z., Monteiro W.R., Corrigan C.J., Hawrylowicz C.M., Griffiths C.J. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015, 70(5):451-457.
59. Lappe J.M., Heaney R.P. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 2012, 4(2):95-100.
60. Manson J.E., Bassuk S.S. Vitamin D research and clinical practice: at a crossroads. J. Am. Med. Assoc. 2015, 313(13):1311-1312.
61. Litonjua A.A., Lange N.E., Carey V.J., Brown S., Laranjo N., Harshfield B.J., O'Connor G.T., Sandel M., Strunk R.C., Bacharier L.B., Zeiger R.S., Schatz M., Hollis B.W., Weiss S.T. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp. Clin. Trials 2014, 38(1):37-50.